tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CYTK Stock Latest News

Cytokinetics price target raised to $83 from $73 at Leerink
The FlyCytokinetics price target raised to $83 from $73 at Leerink
6d ago
CYTK
Cytokinetics price target raised to $71 from $65 at Morgan Stanley
PremiumThe Fly
Cytokinetics price target raised to $71 from $65 at Morgan Stanley
6d ago
CYTK
Cytokinetics price target raised to $64 from $63 at BofA
PremiumThe Fly
Cytokinetics price target raised to $64 from $63 at BofA
6d ago
CYTK
Cytokinetics price target raised to $84 from $70 at Truist
PremiumThe Fly
Cytokinetics price target raised to $84 from $70 at Truist
6d ago
CYTK
Cytokinetics price target raised to $83 from $73 at Leerink
PremiumThe Fly
Cytokinetics price target raised to $83 from $73 at Leerink
6d ago
CYTK
Cytokinetics price target raised to $95 from $87 at RBC Capital
PremiumThe FlyCytokinetics price target raised to $95 from $87 at RBC Capital
6d ago
CYTK
Cytokinetics (CYTK): Myqorzo’s Differentiated Profile, Global Upside, and Pipeline Catalysts Support Raised Target and Buy Rating
Premium
Ratings
Cytokinetics (CYTK): Myqorzo’s Differentiated Profile, Global Upside, and Pipeline Catalysts Support Raised Target and Buy Rating
6d ago
CYTK
Cytokinetics price target raised to $99 from $95 at Goldman Sachs
Premium
The Fly
Cytokinetics price target raised to $99 from $95 at Goldman Sachs
6d ago
BMY
CYTK
Cytokinetics price target raised to $88 from $78 at Citizens
PremiumThe Fly
Cytokinetics price target raised to $88 from $78 at Citizens
6d ago
CYTK
Cytokinetics price target raised to $136 from $120 at H.C. Wainwright
PremiumThe Fly
Cytokinetics price target raised to $136 from $120 at H.C. Wainwright
6d ago
CYTK
Cytokinetics price target raised to $87 from $82 at Barclays
PremiumThe Fly
Cytokinetics price target raised to $87 from $82 at Barclays
7d ago
CYTK
Cytokinetics Gains FDA Approval for MYQORZO in oHCM
PremiumCompany Announcements
Cytokinetics Gains FDA Approval for MYQORZO in oHCM
9d ago
8K
CYTK
Cytokinetics trading resumes
PremiumThe FlyCytokinetics trading resumes
9d ago
CYTK
Cytokinetics announces FDA approval of Myqorzo
Premium
The Fly
Cytokinetics announces FDA approval of Myqorzo
9d ago
CYTK
Cytokinetics trading halted, news pending
Premium
The Fly
Cytokinetics trading halted, news pending
9d ago
CYTK
Cytokinetics upgraded to Buy at Goldman on odds of ACACIA succeeding
PremiumThe Fly
Cytokinetics upgraded to Buy at Goldman on odds of ACACIA succeeding
10d ago
BMY
CYTK
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
PremiumThe Fly
Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
10d ago
CYTK
Cytokinetics Poised for Global Growth with MYQORZO Approval and Anticipated Regulatory Milestones
PremiumRatings
Cytokinetics Poised for Global Growth with MYQORZO Approval and Anticipated Regulatory Milestones
11d ago
CYTK
Cytokinetics announces MYQORZO approved by China NMPA
PremiumThe Fly
Cytokinetics announces MYQORZO approved by China NMPA
11d ago
CYTK
Cytokinetics Receives EU Recommendation for MYQORZO®
PremiumCompany AnnouncementsCytokinetics Receives EU Recommendation for MYQORZO®
16d ago
8K
CYTK
Cytokinetics announces positive CHMP opinion on MYQORZO
Premium
The Fly
Cytokinetics announces positive CHMP opinion on MYQORZO
16d ago
CYTK
Promising Outlook for Cytokinetics: Buy Rating Supported by Aficamten’s Advantages in HCM Treatment
Premium
Ratings
Promising Outlook for Cytokinetics: Buy Rating Supported by Aficamten’s Advantages in HCM Treatment
16d ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >